These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4779132)

  • 1. Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method.
    Rorsman H; Rosengren AM; Rosengren E
    Yale J Biol Med; 1973 Dec; 46(5):516-22. PubMed ID: 4779132
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-S-cysteinyldopa in melanomas of Caucasians.
    Agrup G; Falck B; Jacobsson S; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1974; 54(1):21-22. PubMed ID: 4135162
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
    Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
    Agrup G; Andersson T; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):5-6. PubMed ID: 46673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of cysteinyldopa from glutathionedopa in melanoma.
    Agrup G; Falck B; Kennedy BM; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):1-3. PubMed ID: 46665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopa and 5-S-cysteinyldopa in malignant melanoma in Ugandan Africans.
    Vogel CL; Dhru D; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1974; 54(1):19-20. PubMed ID: 4135161
    [No Abstract]   [Full Text] [Related]  

  • 7. Extraction of dopa from the integument of pigmented animals.
    Cegrell L; Falck B; Rosengren AM
    Acta Physiol Scand; 1970 Jan; 78(1):65-9. PubMed ID: 5419706
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary 5-S-cysteinyldopa levels in patients with malignant melanoma. Preliminary results].
    Césarini JP; Meunier M
    Rev Prat; 1975 Nov; 25(51):4037-9. PubMed ID: 1209143
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of melanogenesis in mouse and guinea pig hair by chemical analysis of melanins and of free and bound dopa and 5-S-cysteinyldopa.
    Ito S; Fujita K; Takahashi H; Jimbow K
    J Invest Dermatol; 1984 Jul; 83(1):12-4. PubMed ID: 6429251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
    Hansson C; Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(2):155-56. PubMed ID: 6155023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.
    Morishima T; Saito M; Hanawa S
    J Dermatol; 1981 Aug; 8(4):301-4. PubMed ID: 6795251
    [No Abstract]   [Full Text] [Related]  

  • 12. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
    Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
    Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
    Graef V; Paul E
    Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
    Ito S; Kato T; Maruta K; Fujita K; Kurahashi T
    J Chromatogr; 1984 Nov; 311(1):154-9. PubMed ID: 6440898
    [No Abstract]   [Full Text] [Related]  

  • 15. Excretion of 5-S-cysteinyldopa in the urine of healthy subjects.
    Agrup G; Falck B; Fyge K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):7-9. PubMed ID: 46677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary excretion of 3,4-dihydroxyphenylalanine (DOPA) and dopamine in hamsters with induced or transplanted melanomas].
    Aubert C; Bohuon C; Comoy E
    C R Acad Hebd Seances Acad Sci D; 1969 Jun; 268(23):2850-2. PubMed ID: 4977597
    [No Abstract]   [Full Text] [Related]  

  • 20. A sensitive method for determination of 5-S-cysteinyldopa.
    Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1973; 53(4):248-50. PubMed ID: 4127449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.